Help Canadians in Medical Need Access Legal Psilocybin Therapy


“I have been able to be happy and anxiety-free and not worry about what’s going to happen tomorrow. I’m able to live in the day and in the moment”

- Laurie Brooks, British Columbia

"For the first time, I feel like I have won the battle in my mind and my anxiety and depression seem to be gone."

- Mona Streleaff, British Columbia

“Psilocybin has been a gentle teacher for me. It expands my ability to BE WITH whatever shows up: the vast range of emotions and challenges that arise when one is dying.”

- Andrea Bird, Ontario
Photo credit: Andreea Muscurel


Our Team

Health Care Professionals

Who we are

Based in Victoria, Canada, and established in 2019, TheraPsil is a non-profit coalition of healthcare professionals, patients, and advocates dedicated to obtaining legal access to psilocybin-assisted psychotherapy for Canadians in medical need. You can meet our team, here.

How does TheraPsil help?

TheraPsil supports Canadians who experience end-of-life distress, to exercise their charter right to seek compassionate treatment using psilocybin, through an application for exemption of section 56(1) of the controlled substances and drug act (CDSA).

TheraPsil then connects approved patients with qualified healthcare professionals who facilitate psilocybin-therapy.

How do I apply?

Check if you qualify & Contact TheraPsil

 Speak with TheraPsil's clinical team to determine if Psilocybin therapy is right for you

Apply for a Psilocybin exemption and await response / approval (approx. 10 days)

Once approved, TheraPsil will connect you with a qualified therapist to facilitate your treatment

Am I eligible?

You are 19+, have been given a terminal diagnosis, are receiving palliative care, OR are in remission from a life-threatening diagnosis (i.e cancer survivor)

Experiencing psychological distress and have not responded to other treatments

Resident of Canada

You are interested in trying Psilocybin Therapy

Sign Up for our Newsletter

Comments are closed.